MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells

JOURNAL ARTICLE published September 2018 in Biomedicine & Pharmacotherapy

Authors: Wenjie Hu | Qilong Liu | Jie Pan | Zheng Sui